A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Fallopian Tube Cancer
Related studies linked through entity extraction aliases.
Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival
- Status
- UNKNOWN
- Phase
- N/A
Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care
- Status
- WITHDRAWN
- Phase
- NA
A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
- Status
- COMPLETED
- Phase
- PHASE3
Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR
- Status
- COMPLETED
- Phase
- N/A
A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE3
Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression
- Status
- COMPLETED
- Phase
- PHASE3
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy
- Status
- UNKNOWN
- Phase
- PHASE3
A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
The Registry of Oncology Outcomes Associated with Testing and Treatment
- Status
- COMPLETED
- Phase
- N/A
Genomic BRCA and Extensive ovArian Cancer Testing
- Status
- COMPLETED
- Phase
- N/A
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers
- Status
- TERMINATED
- Phase
- PHASE1